Life Extension Magazine®

Curcumin linked with blocking long-term inflammation risks

Bio-Enhanced TURMERIC Compounds Block Multiple Inflammatory Pathways

Scientists have identified three compounds—curcumin, ginger, and turmeric oil—that powerfully inhibit the multiple underlying factors behind inflammation. A bio-enhanced process enables the delivery of almost seven times more of these extracts to your bloodstream.

Scientifically reviewed by Dr. Gary Gonzalez, MD, in August 2023. Written by: Michael Downey, Health & Wellness Author.

Bio-Enhanced TURMERIC Compounds Block Multiple Inflammatory Pathways  

Millions of Americans suffer from chronic pain caused by inflammation, while millions more suffer diseases caused by chronic inflammation such as cancer and atherosclerosis.1,2

Prescription options—non-steroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids—target only part of the overall chronic inflammatory response. Worse, they have substantial side effects and are not meant for long-term use.3,4

After combing through scores of nutrients, scientists have identified three compounds: curcumin, ginger, and turmeric oil that inhibit multiple underlying factors behind inflammation—safely reducing both chronic pain and long-term disease risk.

Numerous studies have confirmed that—by targeting the inflammatory origins—these natural extracts reduce the symptoms, risk profiles, and mediating factors of arthritis,5-12 cardiovascular disease,5,13-17 cancer,18-22 and other diseases…and some of these effects are observable in a matter of weeks!9,16,18,23

Even more exciting, scientists have discovered a novel way to deliver more of these three extracts to your bloodstream—almost seven times as much!24-27 These groundbreaking discoveries enhance the ability of these compounds to block the origins of chronic inflammation.

An All-Out Assault On Chronic Inflammation

When levels of certain cellular enzymes are increased, the result is chronic inflammation created by a complex “domino effect” of signaling molecules known as prostaglandins and leukotrienes.28-30 As scientists now know, the more inflammation, particularly chronic inflammation, you have, the more rapidly your body ages.1

In fact, we know that almost all chronic diseases—from arthritis, to heart disease, to diabetes, to Alzheimer’s disease—have one thing in common: destructive, unchecked inflammation.31

Doctors have long known of individual compounds that can inhibit one of the steps involved in chronic inflammation, producing some anti-inflammatory response. For example, NSAIDs inhibit the production of prostaglandin signaling molecules by blocking enzymes known as COX-1 and COX-2. But they are not well characterized in terms of their ability to inhibit production of leukotriene signaling molecules, which requires blocking the LOX enzyme.32

Researchers sought natural compounds that could inhibit the multiple steps behind prostaglandin and leukotriene production to deliver broad-spectrum protection against chronic inflammation.

Unlike current medications, turmeric oil, ginger oil, and curcumin work through multiple mechanisms to block multiple pathways of the inflammation-signaling process.5,32-40

It makes sense that these extracts have similar anti-inflammatory effects—they belong to the same plant family, known as Zingiberaceae.41

Turmeric Root Compounds  

Turmeric Root Compounds

Curcumin is packed with potent chemicals, collectively known as curcuminoids.42

Turmeric oil - the liquid produced during curcumin extraction43,44 - is rich in compounds known as aromatic turmerones.

Ginger Root Compounds

Ginger Root Compounds  

Ginger oil contains gingerols, shogaols, and sesquiterpenes, which are powerful anti-inflammatory active compounds.45

To illustrate a key element of their dramatically broader effectiveness against inflammation, these natural ingredients deliver a potent benefit that no currently available drug can—they block both COX and LOX enzymes, which in turn inhibits synthesis of both prostaglandin and leukotriene signaling molecules!32-40

This is of vital importance, because scientists have now discovered that agents that trigger dual inhibition of COX and LOX enzymes potentially provide “a better therapeutic profile” and produce almost no side effects compared to NSAIDs.32

Remarkably, when these three extracts are combined, they help prevent chronic inflammation by favorably modulating the activity of the following pathways. They:

  • Inhibit COX-1 and COX-2 enzymes;33-35
  • Inhibit LOX enzyme;36-38
  • Inhibit inducible nitric oxide (iNOS);33,36-38
  • Inhibit NF-kappaB;34,37,46
  • Inhibit degradation of IkappaB-alpha;46
  • Exert potent antioxidant activity —scavenging superoxide and hydroxyl radicals and reducing lipid peroxidation, early steps in the inflammation cascade,5,37 and inhibiting transcription of cell surface receptors for oxidized LDL cholesterol;47
  • Inhibit stimulated increase of prostaglandin E2 (PGE2).33

How these natural ingredients work at the cellular level may seem technical, but what you need to remember is that they are not synthetic drugs that are alien to your body’s systems. Instead, they work with your body’s own processes to help bring back natural function. Before we look at the many health benefits of these extracts, let’s learn how scientists have combined all three—in a novel formulation that also delivers a further potent advantage: it naturally enhances absorption.

Enhanced-Absorption Formula

Curcumin has long been known to have poor bioavailability, requiring high doses to achieve desired blood levels.48-59 A new formulation solves this problem in two ways:

Instead of using standard curcumin, this formulation utilizes a curcumin extract that provides better bioavailability than ever thought possible. This “ next generation curcumin” is far more readily absorbed. Its potency is the synergy between the standard extracted curcuminoids plus the added-back, original turmeric compounds that are often removed in commercial processing. These novel, lipid-soluble active compounds called turmerones have been shown in human research to enhance curcumin absorption.27 In fact, two studies showed that it increases curcumin absorption almost 7-fold over a standard curcumin supplement.25,26

The second way this formulation boosts absorption is by including a special kind of molecule called phospholipids. They act as emulsifiers—agents that help oil molecules mix with water—and have been shown to enhance absorption of various nutrients.60 A study confirmed that phospholipids boost curcumin absorption into intestinal cells.61

Let’s now examine some of the health benefits of curcumin, ginger, and turmeric that result from their ability to block the multiple pathways of deadly chronic inflammation.

What You Need to Know
Blocking Chronic Inflammation

Blocking Chronic Inflammation

  • Millions of Americans endure the pain of chronic inflammation; even when pain is not apparent, millions more run the risk of serious diseases triggered by subclinical levels of chronic inflammation.
  • Mainstream medicine offers only drugs that typically target a single aspect of acute inflammatory pain, and that are typically not suitable for long-term use due to substantial side effects.
  • Researchers have found three natural ingredients that block inflammation at multiple stages of the process—inhibiting chronic inflammation at its root.
  • A wealth of clinical trials demonstrates that curcumin, ginger, and turmeric oil safely reduce both chronic pain and slash long-term disease risk, often in only a few weeks.
  • These three extracts have now been combined in a groundbreaking formulation that boosts absorption as much as 7-fold!


Cancer is the second leading cause of death in the United States,62 and according to the American Cancer Society,63one of every three women in the US risks developing some form of cancer over the course of their lives. For men, that number rises to one in two. And inflammation is a major trigger.64

When normal inflammation continues over time and becomes prolonged or chronic, it can cause a multitude of pathologies—including cancers.63 Your body has a natural ability to fight cancer through the activity of tumor-suppressing genes. The science of epigenetics now indicates that both curcumin and gingerol (a key compound in ginger) can—in addition to inhibiting inflammation and modulating cell signaling pathways—reawaken these tumor-suppressing genes, turning them back on to block cancer!65,66

Over two thousand published studies have evaluated the effects of curcumin on many cancers—such as those of the breast, prostate, liver, skin, colon, and lung cancer20,67—by interfering at every stage of the complex sequence of their development, progression, and spread.68 While anticancer drugs often weaken the immune system, curcumin modulates it,68,69-78 serving as an “immune-restorer.”70

In just one of many curcumin studies on animals, scientists grafted human prostate-cancer cells onto special mice that subsequently developed tumors.79 The mice were fed curcumin or placebo five days weekly for four weeks. Afterward, curcumin-fed mice were divided into three groups: one continuing to receive curcumin alone, a second receiving curcumin plus the cancer chemotherapy drug, gemcitabine, and the third receiving curcumin plus radiation treatment.79

Curcumin inhibited cancer growth and enhanced antitumor effects of the drug and radiation. And in an exciting breakthrough, researchers traced these results to a newly discovered mechanism! They found that curcumin reduces expression of a molecule called MDM2—a gene that promotes cancer development, survival, and growth. This mechanism “may be essential for its chemopreventive and chemotherapeutic effects.”79

Ginger research on animals included a study in which scientists orally fed whole ginger extract to mice with prostate cancer. Ginger inhibited tumor growth and progression by 56%, with no detectable toxicity.80 In another study, the active ginger compound 6-gingerol suppressed growth of colorectal cancer cells and tumors in mice by inhibiting synthesis of the signaling molecule leukotriene A4.81

The Power Of Three
The Power Of Three

Ginger (Zingiber officinale) and curcumin (Curcuma longa) are close botanical relatives. Both are rhizomes in the Zingiberaceae family.41 Because of observed “overlapping, but complementary, activities”115—scientists have increasingly focused on the therapeutic effects of combining these two plants.116

They found that “multiple mechanisms of protection against inflammation and oxidative damage make ginger and curcumin particularly promising natural agents in fighting the ravages of aging and degenerative diseases...”116

Turmeric oil is obtained from the potent liquid remaining after curcumin extraction.43,44 Aside from turmeric oil’s own strong anti-inflammatory and antioxidant effects, research revealed that its rich content of compounds called aromatic turmerones massively enhances the absorption of curcumin.27 When turmeric oil was included, a human study demonstrated a 6.93-fold enhancement of bioavailability compared to normal curcumin.25

A newly developed formulation also boosts bioavailability—almost 7-fold—by using an advanced form of curcumin known as BCM-95® that includes lipid soluble active compounds called turmerones, which are normally left behind after curcumin extraction.25

This formulation also contains phospholipids, a type of emulsifying molecule that enhances absorption of poorly soluble active compounds.60,61

When turmeric oil was combined with curcumin in a novel complex, it enhanced bioavailability and completely abolished tumor formation in a mouse model of inflammation-associated colon carcinogenesis.82

These studies demonstrate that the three natural ingredients effectively block multiple pathways of cancer in animals. The real challenge, however, was whether these same plant extracts would be as effective in humans.

Curcumin was given to five patients with Crohn’s disease; an inflammatory condition associated with increased colorectal cancer risk.83 In all but one patient, both disease activity scores and sedimentation rates—a measure of inflammation—improved.84

In familial adenomatous polyposis (FAP), hundreds of colonic polyps form, some of which progress to colorectal cancer. Scientists gave five patients with familial adenomatous polyposis 480 milligrams of curcumin plus 20 milligrams of quercetin three times daily for an average of six months. There was an average 51% decrease in the size of the polyps, and 60% decrease in the number of polyps.85 There was no noticeable toxicity.

Curcumin combined with either soy isoflavones or placebo was given to 85 men and those with high levels of prostate-specific antigen (PSA) were assessed separately. High PSA reflects inflammation and potential prostate cancer risk. After six months, PSA levels were significantly suppressed in the curcumin-isoflavones group.86

Ginger extract was given to one group of healthy volunteers in dosages of 2 grams daily, while others took placebo. On day 28, a colonic biopsy was taken on all participants. There was substantial reduction in average colonic mucosal levels of the inflammation signaling molecule prostaglandin E2 in the ginger subjects. They also had decreased average levels of an intermediate compound called 5-HETE, which is a potent survival factor that certain cancers use to escape destruction.18,125

Turmeric oil in dosages of 600 milligrams, mixed with 3 grams of turmeric extract, was given daily to patients with aggressive premalignant mouth lesions (oral submucous fibrosis), in a pilot study. Subjects showed a substantial decrease in the number of damaged, premalignant cells in both the mucous-membrane mouth lining and in circulating lymphocytes.19

How To Know If You Have Chronic Inflammation
How To Know If You Have Chronic Inflammation

A growing consensus among scientists is that numerous common disorders are caused in part by chronic inflammation.31 For example, when inflammatory cytokines destroy joint cartilage and synovial fluid, arthritis results.92 If cytokines induce an autoimmune attack, they can trigger lupus.

The target of the chronic inflammatory response determines the disease risk. For instance, inflammation can result in brain cell damage and death (resulting in neurodegenerative disease), heart muscle wasting (contributing to congestive heart failure), or coronary atherosclerosis (potentially triggering a heart attack).117-119

Even obesity is related to chronic inflammation.120

Taking action to reduce chronic inflammation can dramatically minimize cellular aging and risk for lethal, age-related diseases.

Testing Inflammation Levels

So how do you know—before it’s too late—if your body is in a state of chronic inflammation?

Life Extension® long ago advised members to have an annual C-reactive protein blood test to detect potentially high levels of systemic inflammation that may be boosting your risk of a host of age-related diseases.31,121

If testing results show your C-reactive protein level is over 1.0 milligrams per liter (1.0 mg/L), this likely indicates that you have inflammatory activity occurring in your body and may be at increased risk for any number of serious medical conditions.122,123

Cardiovascular Disease

Inflammation plays a key role in the development of cardiovascular disease, which is responsible for almost one-in-four American deaths every year.87

Curcumin given to animals on a high-cholesterol diet decreased their total serum cholesterol 21% and their harmful low-density lipoprotein (LDL) by almost 43%, but increased their beneficial high-density lipoprotein (HDL) by 50%!15 Its lipid modulating effects have not been shown to work this well in humans.88

Ginger extract given to diabetic rats, significantly suppressed—in just seven weeks—cholesterol and triglycerides, high levels of which contribute to cardiovascular disease.16 It also significantly lowered blood sugar levels. In another study, ginger extract injected intravenously into rats was shown to significantly lower blood pressure and in a dose-dependent fashion.17

Stents that slowly release turmeric oil were implanted in dogs with blocked arteries. Scientists found that this turmeric-laced stent inhibited the infiltration of dangerous inflammatory cells. It also reduced various factors that often cause new arterial blockages to occur (restenosis).89

After these compelling findings, scientists turned their attention to human trials.

Given to clinical trial volunteers in dosages of 500 milligrams daily, curcumin showed a remarkable 29% increase in HDL cholesterol levels after just seven days.88 Even a one percent increase in this “good” form of cholesterol can reduce heart disease risk—so this finding is important.90

Ginger was shown to enhance efficacy of the antihypertensive drug nifedipine (Procardia®) in human subjects. Combining one gram of ginger with 10 milligrams of the drug daily significantly boosted the anti-platelet aggregation effect in both normal and hypertensive persons.13 This is the tendency of blood cells to clump together, potentially producing a dangerous clot and pathological cardiovascular and cerebrovascular complications.

Blocking Inflammation Can Prevent Obesity And Diabetes
Blocking Inflammation Can Prevent Obesity And Diabetes

In a study released June 18, 2013, ahead of print publication in the journal Molecular Therapy, scientists at the University of Georgia have demonstrated that blocking inflammation can prevent obesity and the early, obesity-related symptoms of diabetes.14

To block inflammation in test animals, researchers sometimes inject interleukin 10 (IL10), an immune-regulating molecule naturally produced by the body to control inflammation.

In this experiment, two groups of mice were fed the same amounts of a high-fat diet. One group was also treated with injections of IL10.

While untreated mice fed a high-fat diet gained weight quickly and began to show the early symptoms of diabetes, those on the diet that were treated with IL10 maintained healthy fat levels and showed no signs of insulin resistance.124

This finding illustrates that lowering chronic inflammation levels in the body may inhibit two of the greatest epidemics of our time—obesity and diabetes—as well as the many other conditions associated with each of these diseases.


People over age 65 make up 65% of all American arthritis patients.91 The hallmarks of the most common form of this joint disease, osteoarthritis, are inflammation and cartilage destruction.92 Fortunately, while both ginger and curcumin block inflammation— curcumin also inhibits cartilage breakdown by the body!93 It does this by protecting the cells found in cartilage called chondrocytes from the inflammatory compounds (IL-1beta and MMP-3) that break them down in arthritis, as well as via other pathways.93

Curcumin strongly blocked rheumatoid arthritis symptoms in animal studies by inhibiting joint inflammation as effectively as methotrexate,6 a drug with serious and sometimes fatal side effects.94 Curcumin improved arthritis scores in mice7 and suppressed osteoarthritis inflammation in dogs.95

Ginger extract blocked inflammatory mediators in a cell culture study—notably the signaling molecule prostaglandin E2—and reduced inflammatory swelling (edema). Researchers described the results as, “a potent suppressive effect on acute and chronic inflammation.”11

Clinical trials have now confirmed these results in humans.

Curcumin in doses of 500 milligrams daily was given to one group of rheumatoid arthritis patients. The NSAID drug diclofenac in doses of 50 milligrams daily was given to a second group. And a combination of the two was given to a third group. The group receiving curcumin-only had the greatest reduction in joint pain and swelling, with no adverse effects. By contrast, nearly 14% of participants in the drug-only group dropped out due to adverse effects!8

Ginger or placebo was given to 29 patients with symptomatic knee arthritis in dosages of four daily capsules of 250 milligrams each. After three months, those taking placebo switched to ginger and those taking ginger switched to placebo, and then the study continued for an additional three months. After a total of six months, the patients experienced significantly less pain and handicap during their ginger-supplemented months than during their placebo months—and reported improvements on a standardized scale used to assess mobility.12

Also, ginger extract given to osteoarthritis patients in doses of 340 milligrams daily for 4 weeks proved equally as effective as 100 milligrams of the drug diclofenac.9 However, the drug group experienced an increase in digestive pain (dyspepsia) and degeneration of their stomach mucosa.9


Among Americans 65 or over, 26.9% have diabetes.96 Diabetics are at risk for pain associated with nerve damage (neuropathic pain),97 accelerated brain aging and cognitive decline (diabetic encephalopathy)98,99 and, of course, high blood sugar. However, the powerful plant extracts we’ve been discussing have the potential to prevent or reverse many of these complications.

Curcumin successfully attenuated experimentally-induced neuropathic pain response—recognized as one of the most difficult types of pain to treat—to mild stimuli (hyperalgesia) in diabetic rats.100 This powerful action is likely due to curcumin’s ability to reduce inflammation signaling molecules called cytokines, reduce the activation of pain signaling molecules and receptors, and reduce the depressive effect of pain.101-107 Also, chronic curcumin treatment reversed much of the extreme inflammation and oxidation damage in the brains of diabetic rats and substantially boosted their performance on memory and cognition tasks.99

Ginger extract was given to diabetic rats, and after just seven weeks, their fasting glucose levels —the blood sugar reading between meals — were significantly reduced.16 The researchers suggested that “ginger may be of great value in managing the effects of diabetic complications of diabetes in human subjects.”16


Memory and cognitive decline often starts about age 50, and by age 80, it is estimated nearly half of all individuals will have some form of cognitive change or dementia.108 As you’ll see, curcumin and ginger offer great promise to stave off this tragedy.

Curcumin administered in animal models of Alzheimer’s has been shown to enhance clearance of amyloid-beta from the brain. This is a malformed protein, the accumulation of which is strongly associated with Alzheimer’s. Curcumin crosses the blood-brain barrier and appears to directly bind to the plaque!109

Scientists fed ginger extract to rats for two weeks before they blocked (occluded) an artery in the brain, and for three weeks afterward. Cognitive testing was done at the end of each of the three weeks following arterial blockage. Researchers found that the ginger extract significantly increased cognitive function and neuron density (in the brain area known as the hippocampus) while significantly decreasing the area of damaged brain tissue—or brain infarct.110

A study team incubated curcumin with macrophages (immune cells) taken from human Alzheimer’s patients. These macrophages are immune cells that normally identify, engulf, and destroy amyloid-beta, but in Alzheimer’s patients these macrophages failed to handle this function.111 In the laboratory, after being treated with curcumin, macrophages from half of the patients significantly increased the amount of amyloid-beta they were able to absorb (uptake).112 These data demonstrate that curcumin may be able to defend against—and even reverse—the Alzheimer’s disease process.

Ginger was tested in a study of 60 healthy middle-aged women who were given 400 or 800 milligrams of the extract, or placebo, daily for two months. Their working memory and cognition were tested before supplementation and after one and two months. The ginger participants showed significantly enhanced working memory, and brain activity consistent with boosted cognitive capability. This suggests that ginger may defend against, and reverse middle-aged cognitive function.113

Turmeric oil was found to exhibit powerful and broad antioxidant activity,5 and data suggest it may suppress neuroinflammation in neurodegenerative diseases, including Alzheimer’s.46,114


Even when pain is not initially apparent, chronic inflammation can eventually lead to serious diseases such as cancer.1,2

Drugs that target acute inflammation are often not suitable for long-term use, and may involve substantial side effects.3,4

In a significant breakthrough, three natural ingredients have been identified that powerfully block the signaling molecules that trigger chronic inflammation.5,32-40

Ginger , curcumin, and turmeric oil block inflammation at multiple points of the process, safely minimizing long-term disease risk.5,32-40

Multiple studies demonstrate that these three extracts combat an array of disorders, including cancer, cardiovascular disease, and arthritis.5-22

These three extracts have been combined in a groundbreaking formulation that greatly boosts absorption!25,27,60,61

If you have any questions on the scientific content of this article, please call a Life Extension® Wellness Specialist at 1-866-864-3027.


  1. Strzelecka M, Bzowska M, Kozieł J, et al. Anti-inflammatory effects of extracts from some traditional Mediterranean diet plants. J Physiol Pharmacol. 2005 Mar;56 Suppl 1:139-56.
  2. Ramos-Nino ME. The role of chronic inflammation in obesity-associated cancers. ISRN Oncol. 2013 May 30;2013:697521.
  3. Peterson K, McDonagh M, Thakurta S, et al. Drug Class Review: Nonsteroidal Antiinflammatory Drugs (NSAIDs): Final Update 4 Report. National Institute of Health (NIH) PubMed Health. Bethesda (MD): National Library of Medicine (US). Nov 2010.
  4. Dixon WG, Bansback N. Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they know. Ann Rheum Dis . 2012 Nov;71(11):1761-4.
  5. Liju VB, Jeena K, Kuttan R. An evaluation of antioxidant, anti-inflammatory, and antinociceptive activities of essential oil from Curcuma longa. L. Indian J Pharmacol. 2011 Sep;43(5):526-31.
  6. Jancinova V, Perecko T, Nosal R, Kostalova D, Bauerova K, Drabikova K. Decreased activity of neutrophils in the presence of diferuloylmethane (curcumin) involves protein kinase C inhibition. Eur J Pharmacol. 2009 Jun 10;612(1-3):161-6.
  7. Moon DO, Kim MO, Choi YH, Park YM, Kim GY. Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model. Int Immunopharmacol. 2010 May;10(5):605-10.
  8. Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res. 2012 Nov;26(11):1719-25.
  9. Drozdov VN, Kim VA, Tkachenko EV, Varvanina GG. Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip. J Altern Complement Med. 2012 Jun;18(6):583-8.
  10. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders. Med Hypotheses. 1992 Dec;39(4):342-8.
  11. Shimoda H, Shan SJ, Tanaka J, et al. Anti-inflammatory properties of red ginger (Zingiber officinale var. Rubra) extract and suppression of nitric oxide production by its constituents. J Med Food. 2010 Feb;13(1):156-62.
  12. Wigler I, Grotto I, Caspi D, Yaron M. The effects of Zintona EC (a ginger extract) on symptomatic gonarthritis. Osteoarth Cartilage. 2003 Nov;11(11):783-9.
  13. Young HY, Liao JC, Chang YS, Luo YL, Lu MC, Peng WH. Synergistic effect of ginger and nifedipine on human platelet aggregation: a study in hypertensive patients and normal volunteers. Am J Chin Med. 2006;34(4):545-51.
  14. Li HL, Liu C, de Couto G, et al. Curcumin prevents and reverses murine cardiac hypertrophy. J Clin Invest. 2008 Mar;118(3):879-93.
  15. Arafa HM. Curcumin attenuates diet-induced hypercholesterolemia in rats. Med Sci Monit. 2005 Jul;11(7):BR228-34.
  16. Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr. 2006 Oct;96(4):660-6.
  17. Ghayur MN, Gilani AH. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J Cardiovasc Pharmacol. January 2005; 45(1):74-80.
  18. Zick SM, Turgeon DK, Vareed SK, et al. Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer. Cancer Prev Res (Phila). 2011 Nov;4(11):1929-37.
  19. Hastak K, Lubri N, Jakhi SD, et al. Effect of turmeric oil and turmeric oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Lett. 1997 Jun 24;116(2):265-9.
  20. Shehzad A, Wahid F, Lee YS. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim). 2010;343(9):489-99.
  21. Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008 Oct 8;269(2):199-225.
  22. Baliga MS, Haniadka R, Pereira MM, et al. Update on the chemopreventive effects of ginger and its phytochemicals. Crit Rev Food Sci Nutr. 2011 Jul;51(6):499-523.
  23. DiSilvestro RA, Joseph E, Zhao S, Bomser J. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J. 2012;11:79.
  24. Available at: %20extracts%20from%20supercritical%20co2%20extraction.pdf. Accessed August 23, 2013.
  25. Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S. A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), A novel bioenhanced preparation of curcumin. Indian J Pharm Sci. 2008 Jul-Aug;70(4):445-9.
  26. Benny M, Antony B. Bioavailability of Biocurcumax (BCM-095™). Spice India. 2006 Sept 9;19(9):11-5.
  27. Yue GG, Cheng SW, Yu H, et al. The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal Caco-2 cells. J Med Food. 2012 Mar;15(3):242-52.
  28. Singh VP, Patil CS, Kulkarni SK. Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats. Pharmacol Biochem Behav. 2005 Jul;81(3):433-9.
  29. Gregus AM, Doolen S, Dumlao DS, et al. Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors. Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6721-6.
  30. Seybold VS, Jia YP, Abrahams LG. Cyclo-oxygenase-2 contributes to central sensitization in rats with peripheral inflammation. Pain. 2003 Sep;105(1-2):47-55.
  31. Chung HY, Cesari M, Anton S, et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2009 Jan;8(1):18-30.
  32. Grzanna R, Lindmark L, Frondoza CG. Ginger—an herbal medicinal product with broad anti-inflammatory actions. J Med Food. 2005 Summer;8(2):125-32.
  33. Li F, Nitteranon V, Tang X, et al. In vitro antioxidant and anti-inflammatory activities of 1-dehydro-[6]-gingerdione, 6-shogaol, 6-dehydroshogaol and hexahydrocurcumin. Food Chem. 2012 Nov 15;135(2):332-7.
  34. Cretu E, Trifan A, Vasincu A, Miron A. Plant-derived anticancer agents - curcumin in cancer prevention and treatment. Rev Med Chir Soc Med Nat Iasi. 2012 Oct-Dec;116(4):1223-9.
  35. Plummer SM, Hill KA, Festing MF, Steward WP, Gescher AJ, Sharma RA. Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1295-9.
  36. Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol. 2007;595:105-25.
  37. Baliga MS, Joseph N, Venkataranganna MV, Saxena A, Ponemone V, Fayad R. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. Food Funct. 2012 Nov;3(11):1109-17.
  38. Tsai KD, Lin JC, Yang SM, et al. Curcumin Protects against UVB-Induced Skin Cancers in SKH-1 Hairless Mouse: Analysis of Early Molecular Markers in Carcinogenesis. Evid Based Complement Alternat Med. 2012;2012:593952.
  39. Flynn DL, Rafferty MF, Boctor AM. Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med. 1986 Jun; 22(3):357-60.
  40. Kiuchi F, Iwakami S, Shibuya M, Hanaoka F, Sankawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem Pharm Bull (Tokyo). 1992 Feb; 40(2):387-91.
  41. Available at: Accessed November 12, 2013.
  42. Verma MK, Najar IA, Tikoo MK, et al. Development of a validated UPLC-qTOF-MS Method for the determination of curcuminoids and their pharmacokinetic study in mice. Daru. 2013 Jan 29;21(1):11.
  43. Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J Agric Food Chem. 1999 Oct;47(10):4297-300.
  44. Jayaprakasha GK, Negi PS, Anandharamakrishnan C, Sakariah KK. Chemical composition of turmeric oil--a byproduct from turmeric oleoresin industry and its inhibitory activity against different fungi. Z Naturforsch C. 2001 Jan-Feb;56(1-2):40-4.
  45. Butt MS, Sultan MT. Ginger and its health claims: molecular aspects. Crit Rev Food Sci Nutr. 2011 May;51(5):383-93.
  46. Park SY, Jin ML, Kim YH, Kim Y, Lee SJ. Anti-inflammatory effects of aromatic-turmerone through blocking of NF-kappaB, JNK, and p38 MAPK signaling pathways in amyloid beta-stimulated microglia. Int Immunopharmacol. 2012 Sep;14(1):13-20.
  47. Lee HS, Lee MJ, Kim H, et al. Curcumin inhibits TNFalpha-induced lectin-like oxidised LDL receptor-1 (LOX-1) expression and suppresses the inflammatory response in human umbilical vein endothelial cells (HUVECs) by an antioxidant mechanism. J Enzyme Inhib Med Chem. 2010 Oct;25(5):720-9.
  48. Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh). 1978;43:86-92.
  49. Ravindranath V, Chandrasekhara N. In vitro studies on the intestinal absorption of curcumin in rats. Toxicology. 1981;20:251-7.
  50. Holder GM, Plummer JL, Ryan AJ. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica. 1978;8:761-8.
  51. Ravindranath V, Chandrasekhara N. Metabolism of curcumin—studies with [3H] curcumin. Toxicology. 1982;22:337-44.
  52. Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology. 1980;16:259-65.
  53. Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Disp. 1999;27:486-94.
  54. Ireson C, Orr S, Jones DJ, et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat In Vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 2001;61:1058-64.
  55. Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML, et al. Metabolism of the cancer preventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev. 2002;11:105-11.
  56. Hoehle SI, Pfeiffer E, Solyom AM, Metzler M. Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. J Agr Food Chem . 2006;54:756-64.
  57. Sharma RA, McLelland HR, Hill KA, et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001;7:1894-900.
  58. Garcea G, Berry DP, Jones DJ. Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev. 2005;14:120-5.
  59. Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10:6847-54.
  60. Available at: Accessed November 12, 2013.
  61. Marczylo TH. Verschoyle RD. Cooke DN. Morazzoni P. Steward WP. Gescher AJ. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol. 2007;60:171-7.
  62. Subramaniam D, Ramalingam S, Houchen CW, Anant S. Cancer stem cells: a novel paradigm for cancer prevention and treatment. Mini Rev Med Chem. 2010 May;10(5):359-71.
  63. Available at: Accessed November 12, 2013.
  64. Vendramini-Costa DB, Carvalho JE. Molecular link mechanisms between inflammation and cancer. Curr Pharm Des. 2012;18(26):3831-52.
  65. Meeran SM, Ahmed A, Tollefsbol TO. Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin Epigenetics. 2010;1(3-4):101-6.
  66. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett. 2008 Aug 18;267(1):133-64.
  67. Johnson JJ, Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett. 2007;255(2):170-81.
  68. Thangapazham RL, Sharma A, Maheshwari RK. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J. 2006;8(3):E443-9.
  69. Jagetia GC, Aggarwal BB. “Spicing up” of the immune system by curcumin. J Clin Immunol. 2007 Jan;27(1):19-35.
  70. Bhattacharyya S, Mandal D, Sen GS, et al. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin. Cancer Res. 2007 Jan 1;67(1):362-70.
  71. Churchill M, Chadburn A, Bilinski RT, Bertagnolli MM. Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res. 2000 Apr;89(2):169-75.
  72. Pal S, Bhattacharyya S, Choudhuri T, et al. Amelioration of immune cell number depletion and potentiation of depressed detoxification system of tumor-bearing mice by curcumin. Cancer Detect Prev. 2005;29(5):470-8.
  73. Perkins S, Verschoyle RD, Hill K, et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):535-40.
  74. South EH, Exon JH, Hendrix K. Dietary curcumin enhances antibody response in rats. Immunopharmacol Immunotoxicol. 1997 Feb;19(1):105-19.
  75. Kurup VP, Barrios CS, Raju R, et al. Immune response modulation by curcumin in a latex allergy model. Clin Mol Allergy. 2007;51.
  76. Xu Y, Ku B, Tie L, et al. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Res. 2006 Nov 29;1122(1):56-64.
  77. Kim GY, Kim KH, Lee SH, et al. Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol. 2005 Jun 15;174(12):8116-24.
  78. Bhattacharyya S, Mandal D, Saha B, et al. Curcumin prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2 induction. J Biol Chem. 2007 Jun 1;282(22):15954-64.
  79. Li M, Zhang Z, Hill DL, Wang H, Zhang R. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res. 2007 Mar 1;67(5):1988-96.
  80. Karna P, Chagani S, Gundala SR, et al. Benefits of whole ginger extract in prostate cancer. Br J Nutr. 2012 Feb;107(4):473-84.
  81. Jeong CH, Bode AM, Pugliese A, et al. [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Res. 2009 Jul 1;69(13):5584-91.
  82. Murakami A, Furukawa I, Miyamoto S, Tanaka T, Ohigashi H. Curcumin combined with turmerones, essential oil components of turmeric, abolishes inflammation-associated mouse colon carcinogenesis. Biofactors. 2013 Mar-Apr;39(2):221-32.
  83. Canavan C, Abrams KR, Mayberry J. Meta-analysis: Colorectal and small bowel cancer risk in patients with Crohn’s disease. Aliment Pharm Ther. 2006;23(8):1097-104.
  84. Holt PR, Katz S, Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci. 2005 Nov;50(11):2191-3.
  85. Cruz-Correa M, Shoskes DA, Sanchez P, et al. Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2006 Aug;4(8):1035-8.
  86. Ide H, Tokiwa S, Sakamaki K, et al. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Prostate. 2010 Jul 1;70(10):1127-33.
  87. Kochanek KD, Xu JQ, Murphy SL, Miniño AM, Kung HC. Deaths: final data for 2009. National Vital Statistics Reports. 2011;60(3).
  88. Soni KB, Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol. 1992 Oct;36(4):273-5.
  89. Zhao JL, Sun BG, Wen QZ. Effect of zedoary turmeric oil-eluting stents for post-stenting restenosis prevention and treatment. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Apr;28(4):326-9.
  90. Boden WE. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial. Am J Cardiol. 2000 Dec 21;86(12A):19L-22L.
  91. Centers for Disease Control and Prevention (CDC) (October 2010). Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2007-2009. MMWR Morb Mortal Wkly Rep. 59(39):1261-5.
  92. Wang Q, Rozelle AL, Lepus CM, et al. Identification of a central role for complement in osteoarthritis. Nat Med. 2011 Nov 6;17(12):1674-9.
  93. Henrotin Y, Clutterbuck AL, Allaway D, et al. Biological actions of curcumin on articular chondrocytes. Osteoarthr Cartilage. 2010;18(2):141-9.
  94. Available at: Accessed November 12, 2013.
  95. Colitti M, Gaspardo B, Della Pria A, Scaini C, Stefanon B. Transcriptome modification of white blood cells after dietary administration of curcumin and non-steroidal anti-inflammatory drug in osteoarthritic affected dogs. Vet Immunol Immunopathol. 2012 Jun 30;147(3-4):136-46.
  96. Available at: Accessed November 13, 2103.
  97. Sorensen L, Molyneaux L, Yue DK. The relationship among pain, sensory loss, and small nerve fibers in diabetes. Diabetes Care. 2006 Apr;29(4):883-7.
  98. Gispen WH, Biessels GJ. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 2000 Nov;23(11):542-9.
  99. Kuhad A, Chopra K. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur J Pharmacol. 2007 Dec 8;576(1-3):34-42.
  100. Sharma S, Kulkarni SK, Agrewala JN, Chopra K. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol. 2006 May 1;536(3):256-61.
  101. Klawitter M, Quero L, Klasen J, et al. Curcuma DMSO extracts and curcumin exhibit an anti-inflammatory and anti-catabolic effect on human intervertebral disc cells, possibly by influencing TLR2 expression and JNK activity. J Inflamm (Lond). 2012;9(1):29.
  102. Li X, Liu RH, Cao H, Li J. Effects of curcumin on behavior and p-ERK, p-CREB, c-fos expression in dorsal root ganglion in chronic constrictive injury rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2009 Aug;25(3):418-22.
  103. Ji FT, Liang JJ, Liu L, Cao MH, Li F. Curcumin exerts antinociceptive effects by inhibiting the activation of astrocytes in spinal dorsal horn and the intracellular extracellular signal-regulated kinase signaling pathway in rat model of chronic constriction injury. Chin Med J (Engl). 2013 Mar;126(6):1125-31.
  104. Dragunow M, Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods. 1989 Sep;29(3):261-5.
  105. Zheng J, Zheng C, Cao H, Li J, Lian Q. [Curcumin down-regulates CX3CR1 expression in spinal cord dorsal horn and DRG in neuropathic pain rats]. Zhongguo Zhong Yao Za Zhi. 2011 Sep;36(18):2552-6.
  106. Yeon KY, Kim SA, Kim YH, et al. Curcumin produces an antihyperalgesic effect via antagonism of TRPV1. J Dent Res. 2010 Feb;89(2):170-4.
  107. Arora V, Kuhad A, Tiwari V, Chopra K. Curcumin ameliorates reserpine-induced pain-depression dyad: behavioural, biochemical, neurochemical and molecular evidences. Psychoneuroendocrinology. 2011 Nov;36(10):1570-81.
  108. Braverman ER, Chen TJ, Prihoda TJ, et al. Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: Evidence supported by structural equation modeling (SEM) parameter estimates. Age (Dordr). 2007 Sep;29(2-3):55-67.
  109. Yang F, Lim GP, Begum AN, et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005 Feb 18;280(7):5892-901.
  110. Wattanathorn J, Jittiwat J, Tongun T, Muchimapura S, Ingkaninan K. Zingiber officinale mitigates brain damage and improves memory impairment in focal cerebral ischemic rat. Evid Based Complement Alternat Med. 2011;2011:429505.
  111. Fiala M, Lin J, Ringman J, et al. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer’s disease patients. J Alzheimers Dis. 2005 Jun;7(3):221-32.
  112. Zhang L, Fiala M, Cashman J, et al. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer’s disease patients. J Alzheimers Dis. 2006 Sep;10(1):1-7.
  113. Saenghong N, Wattanathorn J, Muchimapura S, et al. Zingiber officinale improves cognitive function of the middle-aged healthy women. Evid Based Complement Alternat Med. 2012;2012:383062.
  114. Park SY, Kim YH, Kim Y, Lee SJ. Aromatic-turmerone’s anti-inflammatory effects in microglial cells are mediated by protein kinase A and heme oxygenase-1 signaling. Neurochem Int. 2012 Oct;61(5):767-77.
  115. Bhagavathula N, Warner RL, DaSilva M, et al. A combination of curcumin and ginger extract improves abrasion wound healing in corticosteroid-impaired hairless rat skin. Wound Repair Regen. 2009 May-Jun;17(3):360-6.
  116. Al-Suhaimi EA, Al-Riziza NA, Al-Essa RA. Physiological and therapeutical roles of ginger and turmeric on endocrine functions. Am J Chin Med. 2011;39(2):215-31.
  117. Lyman M, Lloyd DG, Ji X, Vizcaychipi MP, Ma D. Neuroinflammation: The role and consequences. Neurosci Res. 2013 Oct 19.
  118. Glezeva N, Baugh JA. Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target. Heart Fail Rev. 2013 Sep 5.
  119. Li JJ. Inflammation in coronary artery diseases. Chin Med J (Engl). 2011 Nov;124(21):3568-75.
  120. You T, Arsenis NC, Disanzo BL, Lamonte MJ. Effects of exercise training on chronic inflammation in obesity: current evidence and potential mechanisms. Sports Med. 2013 Apr;43(4):243-56.
  121. Kao PC, Shiesh SC, Wu TJ. Serum C-reactive protein as a marker for wellness assessment. Ann Clin Lab Sci. 2006 Spring;36(2):163-9.
  122. Ridker PM. Cardiology patient page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation. 2003 Sep 23;108(12):e81-5.
  123. Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011 Jul-Aug;48(4):155-70.
  124. Gao M, Zhang C, Ma Y, Bu L, Yan L, Liu D. Hydrodynamic delivery of mIL10 gene protects mice from high-fat diet-induced obesity and glucose intolerance. Mol Ther. 2013 Oct;21(10):1852-61.
  125. Sundaram S, Ghosh J. Expression of 5-oxoETE receptor in prostate cancer cells: critical role in survival. Biochem Biophys Res Commun. 2006 Jan 6;339(1):93-8.